We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Immunovant Inc | NASDAQ:IMVT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 27.29 | 25.33 | 35.00 | 0 | 09:00:00 |
From Jun 2023 to Jun 2024
Stifel 2023 Healthcare Conference on Wednesday, November 15, 2023, at 1:50 pm ET
Evercore ISI 6th Annual HealthCONx Conference on Tuesday, November 28, 2023, at 5:05 pm ET
Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, at 11:30 am ET
The fireside chats will be webcast live and can be accessed at https://www.immunovant.com/investors/news-events. An archived webcast will be available for a limited time on Immunovant’s website.
About Immunovant, Inc.Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit www.immunovant.com.Â
Contact:Chau Cheng, PhD, MBAVice President, Investor RelationsImmunovant, Inc.info@immunovant.com
Jaye Bea SmalleyHead, Patient AdvocacyImmunovant, Inc.mediarelations@immunovant.com
1 Year Immunovant Chart |
1 Month Immunovant Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
